XML 104 R89.htm IDEA: XBRL DOCUMENT v3.24.0.1
Net Income Per Share - Additional Information (Detail) - $ / shares
12 Months Ended
Feb. 01, 2021
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Dec. 15, 2019
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Common stock, par value (in dollars per share)   $ 0.125 $ 0.125    
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   200,000 300,000    
Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Basic Net Income (Loss) Per Share   $ 0 $ 0 $ 0  
Participating Securities, Distributed And Undistributed Earnings (Loss), Difference Between Diluted Net Income (Loss) Per Share   $ 0 $ 0 $ 0.01  
Share Equivalents          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   400,000 300,000 0  
Nutrition & Biosciences, Inc          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Business acquisition, equity interest issued or issuable, number of shares 141,740,461        
Common stock, par value (in dollars per share) $ 0.125       $ 0.125
Nutrition & Biosciences, Inc | International Flavors & Fragrances Inc | DuPont de Nemours, Inc [Member]          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Percentage of voting interest acquired 55.40%